Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cluster of climatic and pollutant characteristics increases admissions for acute myocardial infarction: Analysis of 30,423 patients in the metropolitan area of Sao Paulo.
Ribeiro MH, Grossi A, Caixeta A, Franken M, Katz M, Seleme V, Ribeiro E, Pesaro AE, Fabri J Jr, Mehta S, Campos CM. Ribeiro MH, et al. Among authors: caixeta a. Heart Lung. 2021 Mar-Apr;50(2):161-165. doi: 10.1016/j.hrtlng.2020.04.018. Epub 2020 Nov 21. Heart Lung. 2021. PMID: 33227571
Gender-related differences on short- and long-term outcomes of patients undergoing transcatheter aortic valve implantation.
Katz M, Carlos Bacelar Nunes Filho A, Caixeta A, Antonio Carvalho L, Sarmento-Leite R, Alves Lemos Neto P, Eduardo Koenig São Thiago L, Dias Dourado Oliveira A, Antonio Marino M, Tadeu Tumelero R, Antonio Perin M, Abizaid A, Tarasoutchi F, Sândoli de Brito F Jr; Brazilian TAVI Registry investigators. Katz M, et al. Among authors: caixeta a. Catheter Cardiovasc Interv. 2017 Feb 15;89(3):429-436. doi: 10.1002/ccd.26658. Epub 2016 Jul 29. Catheter Cardiovasc Interv. 2017. PMID: 27468953
P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.
Guimarães LF, Généreux P, Silveira D, Pesaro AE, Falcão F, Barbosa BR, de Souza CF, Fonseca FA, Alves CM, Carvalho AC, Stone GW, Caixeta A. Guimarães LF, et al. Among authors: caixeta a. Int J Cardiol. 2017 Mar 1;230:204-208. doi: 10.1016/j.ijcard.2016.12.173. Epub 2016 Dec 27. Int J Cardiol. 2017. PMID: 28062136 Clinical Trial.
Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.
Campos CM, Caixeta A, Franken M, Bartorelli AL, Whitbourn RJ, Wu CJ, Li Paul Kao H, Rosli MA, Carrie D, De Bruyne B, Stone GW, Serruys PW, Abizaid A; ABSORB Cohort B and the SPIRIT II, III, and IV Investigators.. Campos CM, et al. Among authors: caixeta a. Catheter Cardiovasc Interv. 2018 Feb 15;91(3):387-395. doi: 10.1002/ccd.27109. Epub 2017 May 4. Catheter Cardiovasc Interv. 2018. PMID: 28471086 Clinical Trial.
Increased hospitalizations for decompensated heart failure and acute myocardial infarction during mild winters: A seven-year experience in the public health system of the largest city in Latin America.
Levin RK, Katz M, Saldiva PHN, Caixeta A, Franken M, Pereira C, Coslovsky SV, Pesaro AE. Levin RK, et al. Among authors: caixeta a. PLoS One. 2018 Jan 4;13(1):e0190733. doi: 10.1371/journal.pone.0190733. eCollection 2018. PLoS One. 2018. PMID: 29300764 Free PMC article.
Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries.
Caixeta A, Campos CM, Felix C, Chieffo A, Capranzano P, Kawamoto H, Tamburino C, Diletti R, de Ribamar Costa J Jr, Onuma Y, van Geuns RJ, Bartorelli AL, Colombo A, Tamburino C, Serruys PW, Abizaid A. Caixeta A, et al. EuroIntervention. 2019 Sep 20;15(7):623-630. doi: 10.4244/EIJ-D-16-00796. EuroIntervention. 2019. PMID: 30375335 Free article.
171 results